Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 1,957-1,968 of 23,847
Drug study icon
RecruitingISRCTN75061806

Agomelatine (25-50 mg/day) for anxiety

This study is recruiting in China, in Malaysia, in Singapore, .... It is testing agomelatine (25-50 mg/day) for anxiety.

In China
AnxietyOtherOver 18 Years
Countries
China, Malaysia, Singapore, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Anxiety
Drug study icon
RecruitingISRCTN03554974

Agomelatine for anxiety

This study is recruiting in Argentina, in Czechia, in Finland, .... It is testing agomelatine for anxiety.

In Argentina
AnxietyOtherOver 18 Years
Countries
Argentina, Czechia, Finland, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Anxiety
Drug study icon
RecruitingISRCTN28588282

Agomelatine given orally compared to placebo, for depression

This study is recruiting in France. It is testing agomelatine given orally compared to placebo, for depression.

In France
Depression, BipolarityOtherOver 18 Years
Countries
France
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.